Ridgetech Inc
jiuzhou360.comWhat Do They Do?
Distributes pharmaceutical and other healthcare products to trading companies, retail pharmacies, clinics and other vendors in China through offline wholesale and online platforms.
20-F for FY2026, filed Jul 31, 2026We are a wholesale distributor of pharmaceutical and other healthcare products in the People’s Republic of China (“PRC” or “China”). As…View ↗
We currently operate in the offline wholesale distribution of pharmaceutical products primarily to local buyers, while also engaging in…View ↗
Our wholesale customers includes retail pharmacies, clinics and third-party trading companies that purchase from us to resell to pharmacies…View ↗
How Do They Make Money?
The company sells pharmaceutical products wholesale to trading companies and other businesses. For purchases through e-commerce platforms, customers pay through third-party payment services, which reimburse the company within seven days to a month.
20-F for FY2026, filed Jul 31, 2026
-
20-F for FY2026, filed Jul 31, 2026
FY2026 revenue by product or service ↗
$132.2M
-
20-F for FY2026, filed Jul 31, 2026
$132.2M ↗
| Segment | Share | Revenue |
|---|---|---|
|
Revenue from Offline Wholesale
|
89%
FY2023: 100%
|
Revenue from Offline Wholesale, FY2026
$117.9M Sources
|
|
Revenue from Online Platform
|
11% |
Revenue from Online Platform, FY2026
$14.3M Sources
|
Who Are Their Customers?
Wholesale buyers include retail pharmacies, clinics and trading companies that resell to pharmacies. Online sales go through the company’s own and third-party platforms to pharmacies, clinics and other vendors.
20-F for FY2026, filed Jul 31, 2026
20-F for FY2026, filed Jul 31, 2026
For the fiscal year ended March 31, 2026, the Company had one customer that accounted for more than 10% of the Company’s total sales from…View ↗
Do Revenues Turn Into Profits?
No. It lost $1.3M in FY2026.
20-F for FY2026, filed Jul 31, 2026
−$1.9MView ↗
20-F for FY2026, filed Jul 31, 2026
−$1.3MView ↗
20-F for FY2026, filed Jul 31, 2026
−$1.4MView ↗
How Are They Changing?
Shrinking. Revenue fell 20% in 4 years, from $164.4M in FY2022 to $132.2M in FY2026, about 5% a year.
Wholesale-focused model
The older report described retail drugstores, online pharmacy, wholesale distribution and herb farming. The latest describes wholesale distribution through offline sales and online platforms; the retail pharmacy and herb businesses have been divested or ended.
20-F for FY2023, filed Jun 15, 2023 20-F for FY2026, filed Jul 31, 2026We currently operate in four business segments in China: (1) retail drugstores, (2) online pharmacy, (3) wholesale business selling…View ↗
We also offer OTC drugs and nutritional supplements for sale through a website (www.dada360.com) operated by Jiuzhou Pharmacy. For the…View ↗
We also have a herb farming business cultivating and wholesaling herbs used for TCM. This business is conducted through Hangzhou Qianhong…View ↗
Who Do They Compete With?
Competes with Zhengchen Pharmaceutical, Hangzhou Xiaoran Pharmaceutical, Fengwoda Pharmaceutical, and Jiuzhoutong Pharmaceutical
20-F for FY2026, filed Jul 31, 2026The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors…View ↗
Loading...
